BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9407348)

  • 1. Recent advances in the pathophysiology of portal hypertension.
    Tsai YT; Lin HC; Lee SD
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S283-7. PubMed ID: 9407348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of portal hypertension.
    Gupta TK; Chen L; Groszmann RJ
    Clin Liver Dis; 1997 May; 1(1):1-12. PubMed ID: 15562664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
    Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
    Bolognesi M; Di Pascoli M; Verardo A; Gatta A
    World J Gastroenterol; 2014 Mar; 20(10):2555-63. PubMed ID: 24627591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of portal hypertension, what's new?].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2010 Sep; 56(3):129-34. PubMed ID: 20847603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and pathomechanisms of oesophageal varices development.
    Paquet KJ
    Med Sci Monit; 2000; 6(5):915-28. PubMed ID: 11208432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic alterations in cirrhosis and portal hypertension.
    Kim MY; Baik SK; Lee SS
    Korean J Hepatol; 2010 Dec; 16(4):347-52. PubMed ID: 21415576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vasoactive substances and cellular effectors in the pathophysiology of cirrhotic portal hypertension: the past, the present and the future--Georges Brohée Lecture.
    Laleman W
    Acta Gastroenterol Belg; 2009; 72(1):9-16. PubMed ID: 19402365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
    Francque S; Wamutu S; Chatterjee S; Van Marck E; Herman A; Ramon A; Jung A; Vermeulen W; De Winter B; Pelckmans P; Michielsen P
    Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis.
    Di Pascoli M; Sacerdoti D; Pontisso P; Angeli P; Bolognesi M
    J Vasc Res; 2017; 54(2):92-99. PubMed ID: 28402977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.